SinoMab BioScience Limited reported earnings results for the year ended December 31, 2020. For the year, the company reported loss before tax of RMB 122,600,000 as compared to RMB 276,282,000 for the same period last year. Loss for the year was RMB 122,600,000 as compared to RMB 276,282,000 for the same period last year. Basic and diluted loss per share was RMB 0.12 as compared to RMB 0.33 for the same period last year.